A prospective phase II study to determine the efficacy of GDC 0449 (vismodegib) in adults with recurrent medulloblastoma (MB): A Pediatric Brain Tumor Consortium study (PBTC 25B).
Amar J. Gajjar
No relevant relationships to disclose
Sridharan Gururangan
No relevant relationships to disclose
Ibrahim A Qaddoumi
No relevant relationships to disclose
Roger Packer
No relevant relationships to disclose
Stewart Goldman
Consultant or Advisory Role - Novartis
Michael Prados
No relevant relationships to disclose
Annick Desjardins
No relevant relationships to disclose
Maryam Fouladi
No relevant relationships to disclose
Naoko Takebe
No relevant relationships to disclose
Shaoyi Li
No relevant relationships to disclose
David W. Ellison
No relevant relationships to disclose
Tom Curran
No relevant relationships to disclose
Richard J. Gilbertson
No relevant relationships to disclose
James M. Boyett
No relevant relationships to disclose